Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Tamoxifen in Locally Advanced HR+ Breast Cancer (Guatemala)
NCT02806544Phase 2Completed
- Sponsor
- Vanderbilt University
- Start
- Jan 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tamoxifen in breast cancer, sponsored by Vanderbilt University. Started Jan 2013; status: completed.
02
Drugs
tamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02806544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806544.